Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TAM-ing the beast with IL-34 blockade.

Science immunology - 1 Nov 2024

Gyorgypal Aron, Anthony Robert M

Abstract excerpt

TP53 mutation triggers IL-34 secretion by cancer stem cells, reprogramming macrophages to suppress T cells and promote tumor immune escape.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interleukins
Share to Macrophages
Share to Mice
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Neoplastic Stem Cells

Share to Tumor Escape

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 39485858
DOI: 10.1126/sciimmunol.adu0981

Genes

TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TAM-ing the beast with IL-34 blockade.PMID 39485858Read ↗

Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivationSemantic proximity Read ↗

Tumor suppressor p53 deficiency increases tumor immunogenicity through promoting IL33-mediated anti-tumor immune responsesSemantic proximity Read ↗

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer TherapeuticSemantic proximity Read ↗

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.Semantic proximity Read ↗

IL-33 biology in cancer: An update and future perspectivesSemantic proximity Read ↗

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.Semantic proximity Read ↗

IL-27 neutralization enhances macrophage polarization and improves immune checkpoint efficacySemantic proximity Read ↗

CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targetingSemantic proximity Read ↗

With a little help from my T friends: T cells increase efficacy of KRAS (G12D) inhibitors.Semantic proximity Read ↗

microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review).Semantic proximity Read ↗

Applications of the p53/MicroRNA-34 axis beyond cancerSemantic proximity Read ↗

Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.